Maitreya Medicare Limited (NSE:MAITREYA)
India · Delayed Price · Currency is INR 116.00
-5.00 (-4.13%)
Sep 11, 2026, 3:29 PM IST
Maitreya Medicare Revenue
In the fiscal year ending March 31, 2026, Maitreya Medicare had annual revenue of 448.50M INR, down -3.88%. Maitreya Medicare had revenue of 211.51M in the half year ending March 31, 2026, a decrease of -7.92%.
Revenue
448.50M
Revenue Growth
-3.88%
P/S Ratio
1.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
786.02M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 448.50M | -18.12M | -3.88% |
| Mar 31, 2025 | 466.62M | -11.01M | -2.31% |
| Mar 31, 2024 | 477.63M | 83.83M | 21.29% |
| Mar 31, 2023 | 393.80M | -100.32M | -20.30% |
| Mar 31, 2022 | 494.12M | -72.02M | -12.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shalby | 11.76B |
| GPT Healthcare | 4.92B |
| Max India | 2.39B |
| Unihealth Hospitals | 1.32B |
| Sangani Hospitals | 1.08B |
| Vaidya Sane Ayurved Laboratories | 1.07B |
| Gaudium IVF and Women Health | 1.06B |
| Gujarat Kidney And Super Speciality | 1.01B |